The Centers for Medicare & Medicaid Services (CMS) finalized the calendar year (CY) 2027 Medicare Advantage (MA) and Part D rule, largely codifying the Inflation Reduction Act-driven Part D redesign ...

The national average bid amount for Part D plans will increase from $64.28 in 2024 to $179.45 in 2025, according to information released Monday by the Centers for Medicare and Medicaid Services. The ...

The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS. Medicare beneficiaries have two options for ...

Medicare's open enrollment window opens in a few weeks, and the Centers for Medicare & Medicaid Services (CMS) is offering a broad look at the landscape around Medicare Advantage (MA) and Part D ...

On February 15, 2024, the Centers for Medicare and Medicaid Services (CMS) released the Medicare Prescription Payment Plan Draft Part Two Guidance (Part Two Guidance) as part of the Inflation ...

Average premiums for both the Medicare Advantage and Medicare Part D prescription drug programs will decrease next year, driven by regulatory reforms and key provisions from the Inflation Reduction ...

CMS should monitor the effect on Medicare standalone prescription drug plans of changes in how the drug costs of high-cost enrollees are split between the federal government and private insurers. If ...

WASHINGTON, D.C. — In a rare and assertive regulatory move, the Centers for Medicare & Medicaid Services (CMS) has exercised its statutory authority to reject certain standalone prescription drug plan ...

CMS published its final 2027 Medicare Advantage and Part D rule on April 2, enacting changes to star ratings, supplemental benefits administration, Part D coverage, and a series of deregulatory ...